‹ All Posts
Mayank Kumar

22nd Mar 2025 · SEBI-Registered Analyst

PIRAMAL PHARMA

PPLPHARMA
Piramal Pharma: Company arm gets market authorization for Neoatrico from United Kingdom’s Medicines and Healthcare Products Regulatory Agency. (Positive)

#Today’sTradingSetup#StockInNews#Budget2025#FundamentalViews#TechnicalViews
PPLPHARMA_2025-03-22_22-01-54.png
130 likes·80 comments